• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Nellcor buy causes Mallinckrodt loss

Article

One-time charges related to its acquisition of Nellcor Puritan Bennett contributed to a $291.9 million net loss for St. Louis-based Mallinckrodt. The company also reported that earnings in its medical imaging business declined as a result of falling

One-time charges related to its acquisition of Nellcor Puritan Bennett contributed to a $291.9 million net loss for St. Louis-based Mallinckrodt. The company also reported that earnings in its medical imaging business declined as a result of falling prices for contrast media.

For the year, Mallinckrodt reported sales of $2.37 billion, up sharply from $1.7 billion the year before, due to the acquisition of revenues from the Nellcor business. Earnings from continuing operations, not including charges related to the Nellcor purchase, were $132.9 million. Mallinckrodt posted a net profit of $190.1 million the prior year.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.